Logiscreen

Compass Therapeutics Inc

$2.03
Market Cap 365.58M
ROE -39.7%
Gross Margin 0.0%
Debt/Equity 0.1
Current Ratio 19.0
Revenue QoQ 0.0%
EPS QoQ -0.2%
F-Score 3

About

Compass Therapeutics Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-5.31
vs median 35.07
P/B
1.94
vs median 2.20
ROE
-0.40
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

OFIXCATXSIPACBVMDMOBI
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics